10th Antifibrotic Drug Development Summit

Memo

From Exploring Shared Fibrosis Biology and Resolution Mechanisms to Evaluating Human-Relevant Models and Predictive Biomarkers: Navigate Cross-Indication Expansion with Confidence URLs:Tickets: https://go.evvnt.com/3774574-2?pid=5569Brochure: https://go.evvnt.com/3774574-3?pid=5569 Date and Time: On Tue, 01 Dec 2026 08:00 - Thu, 03 Dec 2026 18:00 Venue Details: Hotel Commonwealth, 500 Commonwealth Avenue, Boston, Massachusetts, 02215, United States Category: Conferences Prices:Drug Developer Pricing - Conference + Full Workshop Day: USD 4397.00,Drug Developer Pricing - Conference Only: USD 3099.00,Academic Pricing - Conference + Full Workshop Day: USD 3797.00,Academic Pricing - Conference Only: USD 2699.00,Service Provider Pricing - Conference + Full Workshop Day: USD 5297.00,Service Provider Pricing - Conference Only: USD 3799.00 Speakers: Cedric Hubeau, Head of Tissue Homeostasis and Stromal Biology, Abbvie, Peter Licari, Chief Executive Officer, Animate Biosciences, Inc., Adam Freund, Founder and Chief Executive Officer, Arda Therapeutics, Leslie Nangle Greene, Vice President - Research, aTyr Pharma Inc., Robin mansukhani, CEO, Deciduous Therapeutics, William Newsome, CEO, Fibrocor Therapeutics, Steve De Vos, Head of Translational Sciences, Fibrocor Therapeutics, Marc Hertz, President and Chief Executive Officer, GRI Bio, Inc., Rebecca Taub, Director, Madrigal Pharmaceuticals, Jeffrey Bornstein, CMO, Mediar Therapeutics, Marc Sze, Principal Scientist, Merck and Co, Alexander Barron, Principal Scientist II, Novartis AG, Philipp Tropberger, Senior Principal Scientist, Novartis AG, Mitchell Jones, President and Chief Medical Officer, Palisade Bio, Joerg Heyer, Head of Translational Science and Medicine, Palisade Bio, Thomas Fabre, Senior Principal Scientist, Pfizer, Victor Bustos, Co-Founder and Chief Executive Officer, Refoxy Pharmaceuticals, Zoltan Derdak, Medical Director, Takeda Pharmaceutical, Bernard Allan, Executive Director and Head of Liver Disease Research and Drug Discovery, GI-Ddu, Takeda Pharmaceutical, Ole Kaasboell, CSO, Tribune Therapeutics, John Nicosia, Co-Founder, Vasarya Therapeutics, Ahmed Mousa, Chief Executive Officer, Vicore Pharma Holding, David lagares, Chief Executive Officer, President and Founder, Zenon Biotech